1. Home
  2. BLZE vs TECX Comparison

BLZE vs TECX Comparison

Compare BLZE & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

N/A

Current Price

$12.73

Market Cap

762.0M

Sector

Technology

ML Signal

N/A

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$23.33

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BLZE
TECX
Founded
2007
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
762.0M
618.9M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
BLZE
TECX
Price
$12.73
$23.33
Analyst Decision
Buy
Strong Buy
Analyst Count
7
9
Target Price
$22.83
★ $76.63
AVG Volume (30 Days)
★ 1.5M
233.3K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 58.56
40.70
EPS
★ N/A
N/A
Revenue
★ $145,835,000.00
N/A
Revenue This Year
$18.60
N/A
Revenue Next Year
$25.89
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 14.27
N/A
52 Week Low
$3.26
$15.45
52 Week High
$23.99
$39.53

Technical Indicators

Market Signals
Indicator
BLZE
TECX
Relative Strength Index (RSI) 40.10 33.51
Support Level $12.48 $20.52
Resistance Level $14.45 $30.80
Average True Range (ATR) 0.69 1.39
MACD -0.00 0.11
Stochastic Oscillator 6.84 27.11

Price Performance

Historical Comparison
BLZE
TECX

About BLZE Backblaze Inc.

Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: